BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23776774)

  • 1. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
    Nandha R; Gupta A; Hashmi A
    Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
    Sinha S; Kar C; Das S; Dutta A; De A
    Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.
    Singh PK; Kumar MK; Kumar D; Kumar P
    J Clin Diagn Res; 2015 Jan; 9(1):WC01-3. PubMed ID: 25738068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
    Mittal N; Gupta M; Singla M
    Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.
    Dimri D; Raina RS; Thapliyal S; Thawani V
    J Clin Diagn Res; 2016 May; 10(5):FC01-6. PubMed ID: 27437240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
    Sharma R; Dogra D; Dogra N
    Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance of Cutaneous Adverse Drug Reactions among Patients Attending Dermatology Department at a Tertiary Care Hospital.
    Sharma S; Jayakumar D; Palappallil DS
    Indian Dermatol Online J; 2019; 10(5):547-554. PubMed ID: 31544074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Clinical Spectrum of Cutaneous Adverse Drug Reactions in Patients Presenting at a Tertiary Care Hospital in Pakistan.
    Hina A; Masood S; Jamil S; Tabassum S; Jalil P; Ghulam U
    Cureus; 2021 Apr; 13(4):e14568. PubMed ID: 34026384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Pattern and Causality Assessment of Drug-induced Cutaneous Reactions in a Tertiary Care Hospital in India: A Prospective Study.
    James J; Mohamed AB; Hussain FS; Rani J; Varadarajan S
    Curr Drug Saf; 2022; 17(3):193-198. PubMed ID: 34702154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study of cutaneous adverse drug reactions in a teaching hospital.
    Chopra D; Sharma V; Kapoor R; Dwivedi S
    Int J Clin Pharm; 2015 Dec; 37(6):996-9. PubMed ID: 26238222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
    Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
    Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.
    Chua KY; Tey KE
    Int J STD AIDS; 2022 Aug; 33(9):812-820. PubMed ID: 35775121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    John S; Balakrishnan K; Sukasem C; Anand TCV; Canyuk B; Pattharachayakul S
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
    MachoĊ„ N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
    Sushma M; Noel MV; Ritika MC; James J; Guido S
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.